Clinical Trial Update: Conversion Therapy of Sintilimab in Combination With Fruquintinib and Chemotherapy Versus Sintilimab and Chemotherpay in Stage IV Gastric Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating whether adding Fruquintinib to Sintilimab and chemotherapy improves outcomes versus Sintilimab and chemotherapy alone in …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Adenocarcinoma
• Gastric Cancer
• Gastroesophageal Junction Adenocarcinoma

Drugs mentioned

• Fruquintinib (fruquintinib)
• Sintilimab (sintilimab)

Snippet

Sponsor: Tianjin Medical University Cancer Institute and Hospital | Conditions: Gastric Cancer, Gastric Adenocarcinoma | Phase 2 | Status: NOT_YET_RECRUITING